Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program

PURPOSE: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study was to identify predictive factors of outcome afte...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast
Hlavní autoři: Cabel, Luc, Carton, Matthieu, Pistilli, Barbara, Dalenc, Florence, Vanlemnens, Laurence, Levy, Christelle, Jacot, William, Debled, Michel, Loeb, Agnes, Hennequin, Audrey, De la Motte Rouge, Thibault, Laborde, Lilian, Laurent, Carine, Chamorey, E., Parent, Damien, Petit, Thierry, Mouret-Reynier, Marie-Ange, Campone, Mario, Perrocheau, Geneviève, Labreveux, Claire, Bachelot, Thomas, Robain, Mathieu, Lerebours, Florence
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873471/
https://ncbi.nlm.nih.gov/pubmed/33561617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.01.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky